Patients with multiple sclerosis show robust T-cell responses to mRNA COVID-19 vaccines — ScienceDaily
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment — which depletes the B cells that contribute to the MS attacks — are able to mount robust…
